COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 4/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/24

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Source: supplementary table 3

Description: differential abundance of mothers one week after first dose of BNT162b2 when compared to baseline.

Abundance in Group 1: increased abundance in Mothers at one week post-first dose

NCBI	Quality Control	Links
Acinetobacter radioresistens
Acinetobacter soli
Acinetobacter ursingii
Caldibacillus thermoamylovorans
Empedobacter brevis
Eubacterium ventriosum
Haemophilus haemolyticus
Haemophilus parahaemolyticus
Roseomonas gilardii
unclassified Actinobacillus
unclassified Anoxybacillus
unclassified Bacillus (in: firmicutes)
unclassified Bergeyella
unclassified Brevundimonas
unclassified Duganella
unclassified Empedobacter
unclassified Enhydrobacter
unclassified Flavobacterium
unclassified Janthinobacterium
unclassified Microbacterium
unclassified Paracoccaceae
unclassified Providencia
unclassified Pseudarthrobacter
unclassified Shewanella
unclassified Sphingomonadaceae
unclassified Sphingomonas
Clostridiales bacterium CHKCI001
unclassified Gordonia (in: high G+C Gram-positive bacteria)
unclassified Sphingobacterium
unclassified Allorhizobium-Neorhizobium Pararhizobium-Rhizobiumunclassified Allorhizobium-Neorhizobium Pararhizobium-Rhizobium

Revision editor(s): Folakunmi, ChiomaBlessing